Sobi to present new Aspaveli®/Empaveli® data at ASN Kidney Week 2026 Share Post Post navigation Previous PostHiBy Launches RS2 II Portable Hi-Fi Player with Flagship DARWIN III ArchitectureNext Post Lilly’s Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative colitis